Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
191 - 200 out of 506Page size: 10
  1. 2021
  2. Published

    Diabetes Management in Chronic Kidney Disease: Synopsis of the 2020 KDIGO Clinical Practice Guideline

    Navaneethan, S. D., Zoungas, S., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Liew, A., Michos, E. D., Olowu, W. A., Sadusky, T., Tandon, N., Tuttle, K. R., Wanner, C., Wilkens, K. G., Lytvyn, L., Craig, J. C., Tunnicliffe, D. J., Howell, M., Tonelli, M., Cheung, M. & 4 others, Earley, A., Rossing, Peter, de Boer, I. H. & Khunti, K., 2021, In: Annals of Internal Medicine. 174, 3, p. 385-398

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY Study

    Slieker, R. C., Donnelly, L. A., Fitipaldi, H., Bouland, G. A., Giordano, G. N., Åkerlund, M., Gerl, M. J., Ahlqvist, E., Ali, A., Dragan, I., Elders, P., Festa, A., Hansen, M. K., van der Heijden, A. A., Mansour Aly, D., Kim, M., Kuznetsov, D., Mehl, F., Klose, C., Simons, K. & 15 others, Pavo, I., Pullen, T. J., Suvitaival, T., Wretlind, A., Rossing, Peter, Lyssenko, V., Legido Quigley, C., Groop, L., Thorens, B., Franks, P. W., Ibberson, M., Rutter, G. A., Beulens, J. W. J., 't Hart, L. M. & Pearson, E. R., 2021, In: Diabetes. 70, 11, p. 2683-2693 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Early response in albuminuria and long-term kidney protection during treatment with an endothelin receptor antagonist: A prespecified analysis from the SONAR trial

    Heerspink, H. J. L., Xie, D., Bakris, G., Correa-Rotter, R., Hou, F. F., Kitzman, D. W., Kohan, D., Makino, H., McMurray, J. J. V., Perkovic, V., Rossing, Peter, Parving, H. H. & de Zeeuw, D., 2021, In: Journal of the American Society of Nephrology. 32, 11, p. 2900-2911

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Effect of 26 Weeks of Liraglutide Treatment on Coronary Artery Inflammation in Type 2 Diabetes Quantified by [64Cu]Cu-DOTATATE PET/CT: Results from the LIRAFLAME Trial

    Jensen, Jacob Kildevang, Zobel, E. H., von Scholten, B. J., Rotbain Curovic, V., Hansen, T. W., Rossing, Peter, Kjær, Andreas & Ripa, Rasmus Sejersten, 2021, In: Frontiers in Endocrinology. 12, 10 p., 790405.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Effect of Dapagliflozin on Clinical Outcomes in Patients With Chronic Kidney Disease, With and Without Cardiovascular Disease

    McMurray, J. J. V., Wheeler, D. C., Stefánsson, B. V., Jongs, N., Postmus, D., Correa-Rotter, R., Chertow, G. M., Greene, T., Held, C., Hou, F., Mann, J. F. E., Rossing, Peter, Sjöström, C. D., Toto, R. D., Langkilde, A. M., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: Circulation. 143, 5, p. 438-448

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Effect of Liraglutide on Arterial Inflammation Assessed as [F-18]FDG Uptake in Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial

    Ripa, Rasmus Sejersten, Zobel, E. H., von Scholten, B. J., Jensen, Jacob Kildevang, Binderup, Tina, Diaz, L. J., Curovic, V. R., Hansen, T. W., Rossing, Peter & Kjær, Andreas, 2021, In: Circulation: Cardiovascular Imaging. 14, 7, 13 p., 012174.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    Heerspink, H. J. L., Jongs, N., Chertow, G. M., Langkilde, A. M., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Wheeler, D. C., Greene, T. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: The Lancet Diabetes and Endocrinology. 9, 11, p. 743-754 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial

    Jongs, N., Greene, T., Chertow, G. M., McMurray, J. J. V., Langkilde, A. M., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Stefansson, B. V., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. & DAPA-CKD Trial Committees and Investigators, D. T. C. A. I., 2021, In: The Lancet Diabetes and Endocrinology. 9, 11, p. 755-766 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Effect of liraglutide on expression of inflammatory genes in type 2 diabetes

    Zobel, E. H., Ripa, Rasmus Sejersten, von Scholten, B. J., Rotbain Curovic, V., Kjær, Andreas, Hansen, T. W., Rossing, Peter & Størling, Joachim, 2021, In: Scientific Reports. 11, 18522.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Effect of liraglutide on vascular inflammation evaluated by [64 cu]dotatate

    Zobel, E. H., Ripa, Rasmus Sejersten, von Scholten, B. J., Curovic, V. R., Diaz, L. J., Hansen, T. W., Rossing, Peter & Kjær, Andreas, 2021, In: Diagnostics. 11, 8, 11 p., 1431.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...16 17 18 19 20 21 22 23 ...51 Next

ID: 12937790